Add-on neurological benefits of antiviral therapy in HCV patients with chronic kidney disease — a nationwide cohort study
Hepatitis C virus (HCV)-infected patients with chronic kidney disease (CKD) have rarely been studied because they rarely accept interferon-based therapy (IBT) and have been difficult to follow up. We investiga...
BMC Gastroenterology 2017 17:99
Published on: 16 August 2017